Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaCyclophosphamideTransplantation ChimeraBone Marrow PurgingLiver TransplantationBone Marrow DiseasesHematopoietic Stem CellsGraft SurvivalCombined Modality TherapyTissue DonorsBusulfanTreatment OutcomeHistocompatibility TestingBone Marrow ExaminationHistocompatibilityRecurrenceHematopoiesisTransplantation, IsogeneicLeukemia, Myeloid, AcuteBone Marrow NeoplasmsMice, Inbred C57BLKidney TransplantationTime FactorsRadiation ChimeraPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisRemission InductionLymphoma, Non-HodgkinImmunosuppressive AgentsHematologic NeoplasmsLeukemia, MyeloidGraft RejectionHepatic Veno-Occlusive DiseaseColony-Forming Units AssayStem Cell TransplantationChemotherapy, AdjuvantAcute DiseaseBone RemodelingDisease-Free SurvivalEtoposideGraft vs Host ReactionTransplantation ImmunologySurvival RateMyelodysplastic SyndromesLymphocyte DepletionImmunosuppressionLeukocyte TransfusionCytarabineT-LymphocytesFollow-Up StudiesHematologic DiseasesHeart TransplantationCarmustineChimeraAntineoplastic AgentsActuarial AnalysisSevere Combined ImmunodeficiencyPrognosisRetrospective StudiesGranulocyte Colony-Stimulating FactorHLA AntigensCell DifferentiationCyclosporineMelphalanMultiple MyelomaPancytopeniaLeukocyte CountLymphocyte TransfusionLung TransplantationHodgkin DiseaseLymphomaMethotrexateBone DensitySpleenFlow CytometrySalvage TherapyNuclear FamilyMice, Inbred BALB CCells, CulturedGraft vs Tumor EffectAntigens, CD34Antibodies, MonoclonalOrgan TransplantationAnemia, RefractoryFatal OutcomeGraft vs Leukemia EffectDoxorubicin